{"bill":{"bill_id":1633573,"change_hash":"95e31ee88ceafa5117857fcfc171a9f4","session_id":2003,"session":{"session_id":2003,"state_id":43,"year_start":2023,"year_end":2024,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"88th Legislature Regular Session"},"url":"https:\/\/legiscan.com\/TX\/bill\/SB241\/2023","state_link":"https:\/\/capitol.texas.gov\/BillLookup\/History.aspx?LegSess=88R&Bill=SB241","completed":0,"status":1,"status_date":"2022-11-16","progress":[{"date":"2022-11-16","event":1},{"date":"2023-02-15","event":9}],"state":"TX","state_id":43,"bill_number":"SB241","bill_type":"B","bill_type_id":"1","body":"S","body_id":92,"current_body":"S","current_body_id":92,"title":"Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.","description":"Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.","pending_committee_id":1911,"committee":{"committee_id":1911,"chamber":"S","chamber_id":92,"name":"Health & Human Services"},"referrals":[{"date":"2023-02-15","committee_id":1911,"chamber":"S","chamber_id":92,"name":"Health & Human Services"}],"history":[{"date":"2022-11-16","action":"Received by the Secretary of the Senate","chamber":"S","chamber_id":92,"importance":0},{"date":"2022-11-16","action":"Filed","chamber":"S","chamber_id":92,"importance":1},{"date":"2023-02-15","action":"Read first time","chamber":"S","chamber_id":92,"importance":0},{"date":"2023-02-15","action":"Referred to Health & Human Services","chamber":"S","chamber_id":92,"importance":1}],"sponsors":[{"people_id":11013,"person_hash":"lzwehz7h","party_id":"2","state_id":43,"party":"R","role_id":2,"role":"Sen","name":"Charles Perry","first_name":"Charles","middle_name":"","last_name":"Perry","suffix":"","nickname":"","district":"SD-028","ftm_eid":13006978,"votesmart_id":116957,"opensecrets_id":"","knowwho_pid":292939,"ballotpedia":"Charles_Perry","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":1,"type":"Same As","sast_bill_number":"HB2529","sast_bill_id":1716288}],"subjects":[{"subject_id":5273,"subject_name":"Health"},{"subject_id":5554,"subject_name":"Health--Other Diseases & Medical Conditions"},{"subject_id":5393,"subject_name":"Insurance"},{"subject_id":5497,"subject_name":"Insurance--Health & Accident"},{"subject_id":6091,"subject_name":"DIABETES"},{"subject_id":5336,"subject_name":"MEDICINE & PRESCRIPTION DRUGS"},{"subject_id":5444,"subject_name":"HEALTH & HUMAN SERVICES COMMISSION"}],"texts":[{"doc_id":2613704,"date":"2022-11-16","type":"Introduced","type_id":1,"mime":"text\/html","mime_id":1,"url":"https:\/\/legiscan.com\/TX\/text\/SB241\/id\/2613704","state_link":"https:\/\/capitol.texas.gov\/tlodocs\/88R\/billtext\/html\/SB00241I.htm","text_size":9773,"text_hash":"3c0d946ed4f91104b4cf91684b6680de"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}